Sarepta Therapeutics (SRPT) Change in Receivables (2010 - 2026)
Sarepta Therapeutics' quarterly Change in Receivables came in at -$3.4 million in Q1 2026, down 105.95% year-on-year from $57.4 million in Q1 2025, and down 236.97% quarter-over-quarter from $2.5 million in Q4 2025.
Sarepta Therapeutics has reported Change in Receivables for 17 years, with the latest figure at -$3.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 105.95% year-over-year to -$3.4 million; the trailing twelve-month figure through Mar 2026 stood at -$264.6 million (down 194.29% YoY), and the FY2025 full-year result was -$203.8 million, down 201.04% from the prior year.
- Change in Receivables for Q1 2026 stood at -$3.4 million, down from $2.5 million in the prior quarter.
- The five-year high for Change in Receivables was $167.5 million in Q4 2024, with the low at -$132.1 million in Q2 2025.
- Average Change in Receivables over 5 years is $14.2 million, with a median of $13.0 million recorded in 2023.
- Year-over-year, Change in Receivables soared 3598.81% in 2023 and slumped 602.2% in 2025.
- Tracing SRPT's Change in Receivables over 5 years: stood at $13.1 million in 2022, then soared by 521.02% to $81.5 million in 2023, then surged by 105.55% to $167.5 million in 2024, then plunged by 98.51% to $2.5 million in 2025, then plunged by 236.97% to -$3.4 million in 2026.
- The last three Change in Receivables figures came in at -$3.4 million (Q1 2026), $2.5 million (Q4 2025), and -$131.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | -3.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.42 Mn |
| Mar 31, 2026 | -3.42 Mn |
| Dec 31, 2025 | 2.49 Mn |
| Dec 31, 2025 | 2.49 Mn |
| Sep 30, 2025 | -131.56 Mn |
| Sep 30, 2025 | -131.56 Mn |
| Jun 30, 2025 | -132.08 Mn |
| Jun 30, 2025 | -132.08 Mn |
| Mar 31, 2025 | 57.38 Mn |
| Mar 31, 2025 | 57.38 Mn |
| Dec 31, 2024 | 167.46 Mn |
| Dec 31, 2024 | 167.46 Mn |
| Sep 30, 2024 | 74.53 Mn |
| Sep 30, 2024 | 74.53 Mn |
| Jun 30, 2024 | -18.81 Mn |
| Jun 30, 2024 | -18.81 Mn |
| Mar 31, 2024 | -21.52 Mn |
| Mar 31, 2024 | -21.52 Mn |
| Dec 31, 2023 | 81.47 Mn |
| Dec 31, 2023 | 81.47 Mn |
| Sep 30, 2023 | 82.05 Mn |
| Sep 30, 2023 | 82.05 Mn |
| Jun 30, 2023 | 12.97 Mn |
| Jun 30, 2023 | 12.97 Mn |
| Mar 31, 2023 | 9.21 Mn |
| Mar 31, 2023 | 9.21 Mn |
| Dec 31, 2022 | 13.12 Mn |
| Dec 31, 2022 | 13.12 Mn |
| Sep 30, 2022 | -2.35 Mn |
| Sep 30, 2022 | -2.35 Mn |
| Jun 30, 2022 | 25.66 Mn |
| Jun 30, 2022 | 25.66 Mn |
| Mar 31, 2022 | 25.20 Mn |
| Mar 31, 2022 | 25.20 Mn |
| Dec 31, 2021 | 3.20 Mn |
| Dec 31, 2021 | 3.20 Mn |
| Sep 30, 2021 | 22.27 Mn |
| Sep 30, 2021 | 22.27 Mn |
| Jun 30, 2021 | 9.32 Mn |
| Jun 30, 2021 | 9.32 Mn |
| Mar 31, 2021 | 16.86 Mn |
| Mar 31, 2021 | 16.86 Mn |
| Dec 31, 2020 | -20.49 Mn |
| Dec 31, 2020 | -20.49 Mn |
| Sep 30, 2020 | 17.80 Mn |
| Sep 30, 2020 | 17.80 Mn |
| Jun 30, 2020 | -2.85 Mn |
| Jun 30, 2020 | -2.85 Mn |
| Mar 31, 2020 | 16.00 Mn |
| Mar 31, 2020 | 16.00 Mn |
| Dec 31, 2019 | 22.85 Mn |
| Dec 31, 2019 | 22.85 Mn |
| Sep 30, 2019 | 11.05 Mn |
| Sep 30, 2019 | 11.05 Mn |
| Jun 30, 2019 | 6.47 Mn |
| Jun 30, 2019 | 6.47 Mn |
| Mar 31, 2019 | 1.47 Mn |
| Mar 31, 2019 | 1.47 Mn |
| Dec 31, 2018 | 443,000.00 |
| Dec 31, 2018 | 443,000.00 |
| Sep 30, 2018 | 5.62 Mn |
| Sep 30, 2018 | 5.62 Mn |
| Jun 30, 2018 | 3.14 Mn |
| Jun 30, 2018 | 3.14 Mn |
| Mar 31, 2018 | 10.38 Mn |
| Mar 31, 2018 | 10.38 Mn |
| Dec 31, 2017 | 4.72 Mn |
| Dec 31, 2017 | 4.72 Mn |
| Sep 30, 2017 | 6.96 Mn |
| Sep 30, 2017 | 6.96 Mn |
| Jun 30, 2017 | 5.51 Mn |
| Jun 30, 2017 | 5.51 Mn |
| Mar 31, 2017 | 7.05 Mn |
| Mar 31, 2017 | 7.05 Mn |
| Dec 31, 2016 | 1.24 Mn |
| Dec 31, 2016 | 1.24 Mn |
| Sep 30, 2016 | 4,000.00 |
| Sep 30, 2016 | 4,000.00 |
| Jun 30, 2016 | -8,000.00 |
| Jun 30, 2016 | -8,000.00 |
| Mar 31, 2016 | 13,000.00 |
| Mar 31, 2016 | 13,000.00 |
| Dec 31, 2015 | 1.24 Mn |
| Dec 31, 2015 | 1.24 Mn |
| Dec 31, 2014 | -946,000.00 |
| Dec 31, 2014 | -946,000.00 |
| Sep 30, 2014 | -1.86 Mn |
| Sep 30, 2014 | -1.86 Mn |
| Jun 30, 2014 | -2.62 Mn |
| Jun 30, 2014 | -2.62 Mn |
| Mar 31, 2014 | 4.32 Mn |
| Mar 31, 2014 | 4.32 Mn |
| Dec 31, 2013 | -3.19 Mn |
| Dec 31, 2013 | -3.19 Mn |
| Sep 30, 2013 | 2.56 Mn |
| Sep 30, 2013 | 2.56 Mn |
| Jun 30, 2013 | -1.73 Mn |
| Jun 30, 2013 | -1.73 Mn |
| Mar 31, 2013 | 1.18 Mn |
| Mar 31, 2013 | 1.18 Mn |
| Dec 31, 2012 | -82,000.00 |
| Dec 31, 2012 | -82,000.00 |
| Sep 30, 2012 | -2.38 Mn |
| Sep 30, 2012 | -2.38 Mn |
| Jun 30, 2012 | 1.71 Mn |
| Jun 30, 2012 | 1.71 Mn |
| Mar 31, 2012 | 1.83 Mn |
| Mar 31, 2012 | 1.83 Mn |
| Dec 31, 2011 | 2.42 Mn |
| Dec 31, 2011 | 2.42 Mn |
| Sep 30, 2011 | 6.23 Mn |
| Sep 30, 2011 | 6.23 Mn |
| Jun 30, 2011 | -18.81 Mn |
| Jun 30, 2011 | -18.81 Mn |
| Mar 31, 2011 | 11.23 Mn |
| Mar 31, 2011 | 11.23 Mn |
| Dec 31, 2010 | 4.51 Mn |
| Dec 31, 2010 | 4.51 Mn |
| Sep 30, 2010 | -3.15 Mn |
| Sep 30, 2010 | -3.15 Mn |